Herbert Jamnig
Impact in
- Sensory Systems top 2%
- Olfactory and Sensory Function Studies
- Biomedical Engineering top 2%
- Advanced Chemical Sensor Technologies
Papers in
-
- Lung Cancer Diagnosis and Treatment 4
- Lung Cancer Treatments and Mutations 3
- Medical Imaging and Pathology Studies 2
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
- Oncology 7
- Lung Cancer Research Studies 4
- Co-authors
- Wolfgang Hilbe (16 shared papers)H. Denz (7 shared papers)Michael Fiegl (15 shared papers)Clemens Ager (5 shared papers)Martin Hackl (5 shared papers)Wojciech Filipiak (4 shared papers)Anton Amann (3 shared papers)Martin Klieber (3 shared papers)
- Journals
- Journal of Breath Research (3 papers)Lung Cancer (3 papers)Journal of Clinical Oncology (2 papers)PLoS ONE (1 paper)Journal of Thoracic Oncology (1 paper)
- Partner nations
- AustriaSwitzerlandGermany
In The Last Decade
Herbert Jamnig
21 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 88
- Sensory Systems 185
- Biomedical Engineering 995
- Spectroscopy 363
- Bioengineering 88
- Insect Science 157
Countries citing papers authored by Herbert Jamnig
This map shows the geographic impact of Herbert Jamnig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herbert Jamnig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herbert Jamnig more than expected).
Fields of papers citing papers by Herbert Jamnig
This network shows the impact of papers produced by Herbert Jamnig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herbert Jamnig. The network helps show where Herbert Jamnig may publish in the future.
Co-authors
The 25 scholars most cited alongside Herbert Jamnig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 487 | |
| 2 | 2009 | 222 | |
| 3 | 2012 | 177 | |
| 4 | 2014 | 133 | |
| 5 | 2014 | 123 | |
| 6 | 2014 | 45 | |
| 7 | 2010 | 43 | |
| 8 | 2010 | 37 | |
| 9 | 2011 | 36 | |
| 10 | 2012 | 29 | |
| 11 | 2014 | 23 | |
| 12 | 2018 | 20 | |
| 13 | 2008 | 17 | |
| 14 | Basic clinical parameters predict gefitinib efficacy in non-small cell lung cancer. | 2011 | 16 |
| 15 | 2008 | 9 | |
| 16 | 2007 | 9 | |
| 17 | 2015 | 7 | |
| 18 | 2012 | 4 | |
| 19 | 2010 | 4 | |
| 20 | 2007 | 3 |
About Herbert Jamnig
Herbert Jamnig is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Biomedical Engineering, Molecular Biology and Epidemiology, having authored 22 papers that have together received 1.4k indexed citations. Recurring topics across this work include Advanced Chemical Sensor Technologies (6 papers), Lung Cancer Research Studies (4 papers), Lung Cancer Diagnosis and Treatment (4 papers), Neuroendocrine Tumor Research Advances (3 papers), Lung Cancer Treatments and Mutations (3 papers), Medical Imaging and Pathology Studies (2 papers), Analytical Chemistry and Chromatography (2 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). The work is most often cited by research in Sensory Systems (185 citations), Biomedical Engineering (995 citations), Spectroscopy (363 citations), Bioengineering (88 citations) and Insect Science (157 citations). Herbert Jamnig has collaborated with scholars based in Austria, Switzerland and Germany. Frequent co-authors include Wolfgang Hilbe, H. Denz, Michael Fiegl, Clemens Ager, Martin Hackl, Wojciech Filipiak, Anton Amann, Martin Klieber, Jochen K. Schubert and Wolfgang Weiß. Their work appears in journals such as Journal of Breath Research, Lung Cancer, Journal of Clinical Oncology, PLoS ONE and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.